Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline
- PMID: 6203661
- DOI: 10.1007/BF00401440
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline
Abstract
Experimental and clinical evidence indicates that bleomycin by continuous infusion is superior to intermittent administration. Continuous infusion is less convenient, however. It has been suggested that a suspension of bleomycin in sesame oil, given by IM injection, simulates a continuous infusion. The pharmacokinetics of this formulation have been compared with those of bleomycin in saline following IM injection, in six patients. The pharmacokinetic profiles of the two formulations were similar. The only difference between the profiles was the long terminal half-life at very low concentrations between 12 and 48 h after injection of the oil suspension. This difference is of unknown, but doubtful, clinical significance.
Similar articles
-
A pharmacokinetic evaluation of IM administration of bleomycin oil suspension.Cancer Chemother Pharmacol. 1985;14(3):274-6. doi: 10.1007/BF00258133. Cancer Chemother Pharmacol. 1985. PMID: 2581717
-
[Distribution of bleomycin in sesame oil suspension in organs of rat with mammary carcinoma induced by 7,12-dimethylbenz (a) anthracene and its effect on the tumors (author's transl)].Jpn J Antibiot. 1975 Dec;28(6):753-7. Jpn J Antibiot. 1975. PMID: 53298 Japanese.
-
Serum levels of bleomycin released from the lymphatic system.Haematologia (Budap). 1995;26(3):147-50. Haematologia (Budap). 1995. PMID: 7541012
-
Controlled studies with bleomycin in solid tumors and lymphomas.Prog Biochem Pharmacol. 1976;11:172-84. Prog Biochem Pharmacol. 1976. PMID: 63961 Review. No abstract available.
-
Chemotherapy of male and female germ cell tumors.Semin Oncol. 1992 Apr;19(2 Suppl 5):19-23; discussion 23-4. Semin Oncol. 1992. PMID: 1384139 Review.
Cited by
-
A pharmacokinetic evaluation of IM administration of bleomycin oil suspension.Cancer Chemother Pharmacol. 1985;14(3):274-6. doi: 10.1007/BF00258133. Cancer Chemother Pharmacol. 1985. PMID: 2581717
-
Multivesicular liposomes containing bleomycin for subcutaneous administration.Cancer Chemother Pharmacol. 1991;28(2):105-8. doi: 10.1007/BF00689697. Cancer Chemother Pharmacol. 1991. PMID: 1711933